Skip to main content

Table 3 Multivariate analysis for DFS and OS of diabetic NSCLC patients

From: Prognostic value of metformin for non-small cell lung cancer patients with diabetes

  DFS OS
  p value HR 95% CI p value HR 95% CI
Stage 0.022 1.758 1.157–2.304 0.008 1.510 1.224–1.987
 I       
 II       
 III       
Tumor recurrence 0.017 1.700 1.311–2.247
 No       
 Yes       
Metformin use 0.011 0.687 0.414–0.903 0.035 0.588 0.466–0.895
 No       
 Yes